Eli Lilly (LLY) joins up with India's Strides Arcolab to sell generic cancer treatments in...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

Eli Lilly (LLY) joins up with India's Strides Arcolab to sell generic cancer treatments in emerging markets. Strides will produce the medicines and Eli Lilly sell them, with the agreement initially covering 10 drugs but providing the option for more. The partnership is the latest between Big Pharma, which is seeking growth in developing markets, and Indian generic firms, which want global expertise.